French court cancels Monsanto weedkiller permit on safety grounds
Reuters
Published Jan 15, 2019 09:56AM ET
French court cancels Monsanto weedkiller permit on safety grounds
PARIS (Reuters) - A French court canceled the license for one of Monsanto's glyphosate-based weedkillers on Tuesday over safety concerns, in the latest blow to the Bayer-owned business.
Germany's Bayer (DE:BAYGN), which bought Monsanto (NYSE:MON) for $63 billion last year, faces thousands of U.S. lawsuits by people who say its Roundup and Ranger Pro products caused their cancer.
A court in Lyon in southeast France ruled that the approval granted by French environment agency ANSES in 2017 for Roundup Pro 360 had failed to take into account potential health risks.
Bayer has cited regulatory rulings as well as scientific studies that found glyphosate to be safe and the firm is appealing a first U.S. court ruling that awarded $78 million in damages to a school groundskeeper from California.
Glyphosate, which is off-patent and marketed worldwide by dozens of other chemical groups including Syngenta and DowDuPont's Corteva Agriscience, is due to be phased out in France within three years under a pledge by President Emmanuel Macron, who stopped short of an outright ban.
The French court said ANSES had not respected a precautionary principle in French law, notably by not conducting a specific evaluation of health risks for Roundup Pro 360.
"Despite the European Union's approval of the active substance (glyphosate), the court considered that scientific studies and animal experiments showed Roundup Pro 360, a preparation whose toxicity is greater than that of glyphosate, is a potentially carcinogenic product for humans, suspected of being toxic for human reproduction and for aquatic organisms," the court said in a summary of its ruling.
Neither ANSES nor Bayer had immediate comment on the ruling.
"This is a great first, which must be repeated," Corinne Lepage, a former French environment minister and member of environment association CRIIGEN that brought the court case, said of the ruling on Twitter.
The association had also contested the process by which the EU renewed the general license for glyphosate, seeking a referral to the European Court of Justice, but the French administrative court said such action was not necessary.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.